Shandong Loncom Pharmaceutical Co.Ltd.

T1D89
China Mainland
Company Profile
  • Year Established: 2012
  • Total Assets(USD): 500,000 to 99,999,999
  • Total Number of Staff: 500-1000
  • Main Competitive Advantages: Experienced R&D Staff,Small Orders Accepted
  • Business Type: Manufacturer
  • R&D Capacity: OEM,ODM,Own Brand
  • Annual Turnover(USD) : 500,000 to 99,999,999
  • Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Founded in May 2012, the company is a wholly-owned subsidiary of Shandong Bainuo Pharmaceutical Co., LTD., located in Qihe, Shandong province, near the Yellow River known as the "Pearl of the Yellow River", covering an area of 200 mu, with a registered capital of 60 million yuan. The company has built API pilot trial, production base and preparation production base in accordance with international standards of Europe and the United States, and has 13 production lines for oral solid preparation, oral liquid preparation and API. Small volume injection, soft capsule, eye drops, external medicine and other preparation workshops, as well as innovative drug RESEARCH and development center are stepping up construction, and will eventually build into a comprehensive modern high-tech pharmaceutical enterprise integrating research and development, production and marketing of new pharmaceutical products.

Year Established: 2012

Total Assets(USD): 500,000 to 99,999,999

Total Number of Staff: 500-1000

Main Competitive Advantages: Experienced R&D Staff,Small Orders Accepted

Business Type: Manufacturer

R&D Capacity: OEM,ODM,Own Brand

Annual Turnover(USD) : 500,000 to 99,999,999

Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Top Products
Copyright 2006-2022 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by